ADDENDUM. to the scientific Opinions on Climbazole (P64) ref. SCCS/1506/13 and SCCS/1590/17
|
|
- Oscar Lawrence
- 5 years ago
- Views:
Transcription
1 Version S Scientific Committee on Consumer Safety SCCS ADDENDUM to the scientific Opinions on Climbazole (P64) ref. SCCS/1506/13 and SCCS/1590/17 The SCCS adopted this document at its plenary meeting on June 2018
2 ACKNOWLEDGMENTS SCCS members Dr U. Bernauer Dr L. Bodin Prof. Q. Chaudhry Prof. P.J. Coenraads Prof. M. Dusinska Dr J. Ezendam Dr E. Gaffet Prof. C. L. Galli Dr B. Granum Prof. E. Panteri Prof. V. Rogiers Dr Ch. Rousselle Dr M. Stepnik Prof. T. Vanhaecke Dr S. Wijnhoven (Rapporteur) This Addendum to the Opinion is final and was not subject to a commenting period as requested by the mandating DG because the terms of reference requested a revision of the calculation on margin of safety only. Keywords: SCCS, addendum, scientific opinion, Climbazole, preservative, P64, CAS , EC , SCCS/1600/18, Regulation 1223/2009 Opinion to be cited as: SCCS (Scientific Committee on Consumer Safety), Addendum to the scientific Opinions on climbazole (P64) ref. SCCS/1506/13 and SCCS/1590/17, final version adopted on June 2018, SCCS/1600/18 All Declarations of Working Group members are available on the following webpage: 2
3 About the Scientific Committees Two independent non-food Scientific Committees provide the Commission with the scientific advice it needs when preparing policy and proposals relating to consumer safety, public health and the environment. The Committees also draw the Commission's attention to the new or emerging problems which may pose an actual or potential threat. They are: the Scientific Committee on Consumer Safety (SCCS) and the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) and are made up of scientists appointed in their personal capacity. In addition, the Commission relies upon the work of the European Food Safety Authority (EFSA), the European Medicines Agency (EMA), the European Centre for Disease prevention and Control (ECDC) and the European Chemicals Agency (ECHA). SCCS The Committee shall provide Opinions on questions concerning all types of health and safety risks (notably chemical, biological, mechanical and other physical risks) of non-food consumer products (for example: cosmetic products and their ingredients, toys, textiles, clothing, personal care and household products such as detergents, etc.) and services (for example: tattooing, artificial sun tanning, etc.). Scientific Committee members Bernauer Ulrike, Bodin Laurent, Chaudhry Mohammad Qasim, Coenraads Pieter-Jan, Dusinska Maria, Ezendam Janine, Gaffet Eric, Galli Corrado Lodovico, Granum Berit, Panteri Eirini, Rogiers Vera, Rousselle Christophe, Stępnik Maciej, Vanhaecke Tamara, Wijnhoven Susan Contact European Commission Health and Food Safety Directorate C: Public Health, Country Knowledge, Crisis Management Unit C2 Country Knowledge and Scientific Committees L-2920 Luxembourg European Union, 2018 ISSN Doi: ISBN ND- The opinions of the Scientific Committees present the views of the independent scientists who are members of the committees. They do not necessarily reflect the views of the European Commission. The opinions are published by the European Commission in their original language only. 3
4 TABLE OF CONTENTS ACKNOWLEDGMENTS MANDATE FROM THE EUROPEAN COMMISSION OPINION CONCLUSION MINORITY OPINION REFERENCES
5 1. MANDATE FROM THE EUROPEAN COMMISSION Background The cosmetic ingredient Climbazole (CAS ), with the chemical name 1-(4- chlorophenoxy)-1-imidazol-1-yl-3,3-dimethyl-2-butanone, is currently regulated in the Cosmetics Regulation (EC) 1223/2009 as a preservative in Annex V, entry 32, up to a maximum authorized concentration of 0.5%. Climbazole has been subject to different safety evaluations by the SCCP in 2005 (SCCP/0918/05 1 ) and 2009 (SCCP/1204/08 2 ) and by the SCCS in 2013 (SCCS/1506/13 3 and SCCS/1500/13 4 ). In October 2017 the SCCS adopted an addendum (SCCS/1590/17)5 to the opinion of Climbazole (P64) ref. SCCS/1506/13 that concludes: The maximum concentrations of Climbazole considered as safe for human health under an aggregate exposure scenario are as follows: 2% as anti-dandruff agent in rinse-off shampoos and 0.2% as cosmetic preservative in leave on formulations (face cream, hair lotion, foot care) with the exception of cosmetics applied on a full body area (body lotion). Following the SCCS opinion, a discussion was held at the Working Group on Cosmetic Products on 28 February 2018 with a view to a COM proposal for a draft Regulation on Climbazole as preservative and as an anti-dandruff in rinse-off shampoos. During this discussion, Cosmetics Europe highlighted that Climbazole should also be safe for use as a preservative in rinse-off shampoos at 0.5%. Further to concerns raised by Member States on this specific use, a re-assessment on the safety of Climbazole as a preservative in rinse-off shampoos is needed. At the same time, considering the need to evaluate the aggregate exposure for cosmetics, it is appropriate to reassess the use of Climbazole for the different categories of relevant products and concentrations as follows
6 Terms of reference (1) In light of the SCCS addendum (SCCS/1590/17), does the SCCS consider safe the use of Climbazole (CAS ) when used in cosmetic products in the following specified concentrations under an aggregate exposure scenario for cosmetics: As a cosmetic preservative in face cream up to a concentration of 0.2%;? As a cosmetic preservative in hair lotion up to a concentration of 0.2%; As a cosmetic preservative in foot care up to a concentration of 0.2%; As a cosmetic preservative in rinse-off shampoo up to a concentration of 0.5%; As an anti-dandruff agent in rinse-off shampoo up to a concentration of 2.0%. (2) If not, what is according to the SCCS, the maximum concentration considered safe for use of Climbazole (CAS ) as a cosmetic preservative respectively in face cream, hair lotion, foot care and rinse-off shampoo as well as anti-dandruff agent in rinse-off shampoo under an aggregate exposure scenario for cosmetics? 6
7 2. OPINION In the current mandate and in light of the SCCS Addendum (SCCS/1590/17), the SCCS is being asked to re-evaluate the safety levels of Climbazole in different specified concentrations in different cosmetic formulations (as preservative in face cream, hair lotion, foot care, rinse-off shampoo and as antidandruff agent in rinse-off shampoo) under an aggregate exposure scenario for cosmetics. 2.1 Relevant Information taken from the previous opinions Calculation for the use of Climbazole at 2% as an anti-dandruff agent in shampoo Dermal absorption through human skin A (μg/cm²) = µg/cm² Skin Area surface (area hand + ½ area head) SAS (cm²) = 1440 cm² Frequency of application of the finished product F (day -1 ) = 1.00 Typical human body weight = 60 kg Systemic exposure dose (SED) A x (10-3 mg/µg) x SAS x F /60 = mg/kg bw No observed effect level NOEL = 5 mg/kg bw/day (90 day, oral, rat) Margin of Safety NOEL/ SED = 413 Calculation for the use of Climbazole as preservative at 0.2% in aqueous hair lotions Dermal absorption through human skin* A (μg/cm²) = µg/cm² Skin area surface (area hand + ½ area head) SAS (cm²) = 1440 cm² Frequency of application of the finished product F (day-1) = 1.00 Typical human body weight = 60 kg Systemic exposure dose (SED) A x (10-3 mg/µg) x SAS x F / 60 kg = mg/kg bw No observed effect level NOEL = 5 mg/kg bw/day (90 day, oral, rat) Margin of Safety NOEL / SED = 303 7
8 Calculation for the use of Climbazole as preservative at 0.2% in a cosmetic face cream: application 2.14 times/day according to frequency of application per product type by Bremmer et al. (2006a, 2006b) and SCCS/1564/15 Dermal absorption through human skin A (μg/cm²) = µg/cm² Skin area surface (1/2 area head female) SAS (cm²) = 565 cm² Frequency of application of the finished product F (day -1 ) = 2.14 Typical human body weight = 60 kg Systemic exposure dose (SED) A x (10-3 mg/µg) x SAS x F / 60 kg = mg/kg bw No observed effect level NOEL = 5 mg/kg bw/day (90 day, oral, rat) Margin of Safety NOEL / SED = 361 Calculation for the use of Climbazole as preservative at 0.5% in leave-on body lotion: application 2.28 times/day (according to frequency of application per product type by Bremmer et al. (2006a, 2006b) and SCCS/1564/15 Dermal absorption through human skin A (μg/cm²) = µg/cm² Skin area surface (whole body) SAS (cm²) = 18,000 cm² Frequency of application of the finished product F (day -1 ) = 2.28 Typical human body weight = 60 kg Systemic exposure dose (SED) A x (10-3 mg/µg) x SAS x F / 60 kg = mg/kg bw No observed effect level NOEL = 5 mg/kg bw/day (90 day, oral, rat) Margin of Safety NOEL/ SED = 4 8
9 Calculation for the use of Climbazole as preservative up to 0.2% in foot care products Dermal absorption through human skin* A (μg/cm 2 ) = µg/cm² Skin area surface (feet, Ref. 2) SAS (cm 2 ) = 1170 cm 2 Frequency of application of the finished product F (day -1 ) = 1.00 Typical human body weight = 60 kg Systemic exposure dose (SED) A x (10-3 mg/µg) x SAS x F/ 60 kg = mg/kg bw No observed effect level NOEL = 5 mg/kg bw/day (90 day, oral, rat) Margin of Safety NOEL / SED = 373 * dermal absorption A (μg/cm 2 ) has been proportionally adjusted for the lowered concentration of Climbazole 2.2 Current Request In a current request, the applicant requests the extension of the use of Climbazole as preservative at maximal concentration of 0.5% in shampoos. The following calculation of the MoS for that particular application is as follows: Calculation for the use of Climbazole at 0.5 % as preservative in shampoo Dermal absorption through human skin A (μg/cm²)* = µg/cm² Skin Area surface (area hand + ½ area head) SAS (cm²) = 1440 cm² Frequency of application of the finished product F (day -1 ) = 1.00 Typical human body weight = 60 kg Systemic exposure dose (SED) A x (10-3 mg/µg) x SASx F / 60 kg = mg/kg bw No observed effect level NOEL = 5 mg/kg bw/day (90 day, oral, rat) Margin of Safety NOEL/ SED = 1653 * dermal absorption A (μg/cm2) has been proportionally adjusted for the requested, lowered concentration of Climbazole 9
10 The individual uses of Climbazole and under an aggregate exposure scenario (Table 1 and 2), except its use as preservative up to 0.5% for whole body applications (MoS= 4), are considered safe: - as an anti-dandruff compound up to 2% in cosmetic shampoos (MoS= 413), - as a preservative compound up to 0.5 % in cosmetic shampoos (MoS= 1653), - as preservative up to 0.2% in an aqueous hair lotion (MoS= 196), - as preservative up to 0.2% in a face cream (MoS= 144), - as preservative up to 0.2 % in foot care (MoS= 241). Table 1 Combined use of Climbazole as preservative at a maximum concentration of 0.2% in leave-on and rinse-off cosmetic products and as an anti-dandruff agent in shampoo at 2%; realistic frequency of use values and conservative absorption values +1SD were taken into consideration; Inclusion A* SAS F bw NOEL MoS % (ug/cm 2 ) (cm 2 ) (day -1 SED Product type ) (kg) (mg/kg/day) Shampoo (anti-dandruff) hair lotion face cream foot care shampoo + hair lotion shampoo + face cream shampoo + foot care hair lotion + face cream hair lotion + foot care face cream + foot care shampoo + hair lotion + face cream shampoo + hair lotion + foot care shampoo + face cream + foot care hair lotion + face cream + foot care Shampoo(2%) + hair lotion + face cream foot care 5 89 *Dermal absorption values were proportionally adjusted. NOTE: only cosmetic products with MoS 100 were included in combined-use calculations. 10
11 Tab. 2 Combined use of Climbazole as preservative at a maximum concentration of 0.2% in leave-on cosmetic products and 0.5% in shampoo; realistic frequency of use values and conservative absorption values +1SD were taken into consideration; Inclusion A* SAS F bw NOEL MoS % (ug/cm 2 ) (cm 2 ) (day -1 SED Product type ) (kg) (mg/kg/day) Shampoo (preservative) hair lotion face cream foot care shampoo + hair lotion shampoo + face cream shampoo + foot care hair lotion + face cream hair lotion + foot care face cream + foot care shampoo + hair lotion + face cream shampoo + hair lotion + foot care shampoo + face cream + foot care hair lotion + face cream + foot care Shampoo(0.5%) + hair lotion + face cream foot care 5 *Dermal absorption values were proportionally adjusted. NOTE: only cosmetic products with MoS 100 were included in combined-use calculations. 3.3 Discussion In light of the addendum (SCCS/1590/17), the SCCS recalculated the SED and MoS values according to the principles of the Notes of Guidance [SCCS/1564/15]. The proposed concentrations of Climbazole as a cosmetic preservative: - in face cream up to a concentration of 0.2%; - in hair lotion up to a concentration of 0.2%; - in foot care up to a concentration of 0.2%; - in rinse-off shampoo up to a concentration of 0.5%; are considered safe as well individually as under a conservative deterministic aggregate exposure scenario (as preservative in shampoo(0.5%) + hair lotion + face cream + foot care). 11
12 When Climbazole is present as an anti-dandruff agent in rinse-off shampoo up to a concentration of 2.0%, it is considered to be safe as well individually as under a conservative deterministic aggregate exposure scenario (as anti-dandruff in shampoo (2%) + hair lotion + face cream + foot care). The SCCS used the 4-cosmetic products combination in its calculation as it considers that the 5-cosmetic products combination including the combined use of both shampoos (as preservative only and with anti-dandruff action) is unrealistic. 3. CONCLUSION (1) In light of the SCCS addendum (SCCS/1590/17), does the SCCS consider safe the use of Climbazole (CAS ) when used in cosmetic products in the following specified concentrations under an aggregate exposure scenario for cosmetics: As a cosmetic preservative in face cream up to a concentration of 0.2%; As a cosmetic preservative in hair lotion up to a concentration of 0.2%; As a cosmetic preservative in foot care up to a concentration of 0.2%; As a cosmetic preservative in rinse-off shampoo up to a concentration of 0.5%; As an anti-dandruff agent in rinse-off shampoo up to a concentration of 2.0%. o o The SCCS considers the specified concentrations when used as preservative, for the individual cosmetic products as well as for their combinations under aggregate exposure scenario as safe When Climbazole is used as an anti-dandruff agent up to 2%, the 4-cosmetic products combination (with hair lotion, face cream and foot care) is also considered as safe o The SCCS therefore considers that the use of climbazole up to a concenration of 2% in shampoos is safe for the consumer, either as anti-dandruff agent or as a preservative agent in combination with other uses and at concentrations as listed above. (2) If not, what is according to the SCCS, the maximum concentration considered safe for use of Climbazole (CAS ) as a cosmetic preservative respectively in face cream, hair lotion, foot care and rinse-off shampoo as well as anti-dandruff agent in rinse-off shampoo under an aggregate exposure scenario for cosmetics? / 4. MINORITY OPINION / 12
13 5. REFERENCES 1. Bremmer H.J., Prud'Homme de Lodder L.C.H., van Engelen J.G.M. Cosmetics Fact Sheet to assess the risks for the consumer, Updated version for ConsExpo4. RIVM Report /2006 (2006a) 2. Bremmer H.J., Prud'Homme de Lodder L.C.H., van Engelen J.G.M. General Fact Sheet - Limiting conditions and reliability, ventilation, room size, body surface area. Updated version for ConsExpo 4, RIVM report /2006 (2006b). 3. ECHA Decision on substance evaluation pursuant to Article 46(1) of Regulation (EC) No 1907/2006 (REACH) for Climbazole, CAS No (EC No ) (public version). 30 June ad decf06b9ea8 4. Pérez-Rivera A.A., Hu T., Aardema M.J.,Nash J.F. Evaluation of the genotoxicity of the imidazole antifungal climbazole: Comparison to published results for other azole compounds. Mut. Res.672: (2009). 5. SCCP/0918/05, Opinion on Climbazole (Colipa n P64), Adopted by the SCCP during the 5th plenary meeting of 20 September SCCP/1204/08. Opinion on Climbazole (Colipa n P64), adopted by the SCCP during the 19th plenary meeting of 21 January SCCS/1500/13 Opinion on Climbazole regarding potential development of (cross)- resistance Cosmetics Europe: P64 8. SCCS/1506/13, Addendum to the Opinion SCCS/1506/13 On Climbazole Cosmetics Europe: P64, Revision of 18 June SCCS/1564/15, SCCS Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation 9th revision, 29 September 2015, revision of 25 April Sietsema WK The absorption oral bioavailability of selected drugs. Int J Clin Pharmacol Ther Toxicol 27:179±
Scientific Committee on Consumer Safety (SCCS) PLENARY. Venue: Luxembourg. Meeting date: 19 September Minutes
Scientific Committee on Consumer Safety (SCCS) PLENARY Venue: Luxembourg Meeting date: 19 September 2013 Minutes 1. WELCOME AND APOLOGIES The Chair welcomed the participants and took note of one apology.
More informationScientific Committee on Consumer Safety (SCCS) 5 th PLENARY. Venue: Luxembourg. Meeting date: 27 March Minutes
Scientific Committee on Consumer Safety (SCCS) 5 th PLENARY Venue: Luxembourg Meeting date: 27 March 2014 Minutes 1. WELCOME AND APOLOGIES The Chair welcomed all the participants. There was no apology.
More informationPIROCTONE OLAMINE AND ITS MONOETHANOLAMINE SALT
SCCNPF/0525/01 OPINION OF THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS CONCERNING PIROCTONE OLAMINE AND ITS MONOETHANOLAMINE SALT Colipa n P59 adopted by the
More informationScientific Committee on Consumer Safety (SCCS) 6 th PLENARY. Venue: Luxembourg. Meeting date: 18 June Minutes
Scientific Committee on Consumer Safety (SCCS) 6 th PLENARY Venue: Luxembourg Meeting date: 18 June 2014 Minutes 1. WELCOME AND APOLOGIES The Chair welcomed all the participants. There were two apologies.
More informationEUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL. Held on 24 June 2008 in Brussels MINUTES
EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Directorate C Public Health and Risk Assessment C7 Risk assessment Scientific Committee on Consumer Products SCIENTIFIC COMMITTEE ON CONSUMER
More informationCouncil of the European Union Brussels, 7 October 2016 (OR. en)
Council of the European Union Brussels, 7 October 2016 (OR. en) 13062/16 COVER NOTE From: European Commission date of receipt: 6 October 2016 To: No. Cion doc.: D047413/01 Subject: General Secretariat
More informationPIF Introduction Including Safety Assessment
PIF Introduction Including Safety Assessment Cosmetics Information Day, September 15 th 2010 Dr. Sarah O Meara, Pre-clinical Assessor, Irish Medicines Board The content of this presentation does not purport
More informationMemorandum on hair dye Chemical Sensitisation
Scientific Committee on Consumer Safety SCCS Memorandum on hair dye Chemical Sensitisation The SCCS adopted this memorandum at its 18 th Plenary meeting of 26 February 2013 About the Scientific Committees
More informationOfficial Journal of the European Union
L 36/12 EN COMMISSION REGULATION (EU) 2017/237 of 10 February 2017 amending Annex III to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)
More informationUnderstanding the Cosmetic Products Regulation 1223/2009 and REACH
1 Understanding the Cosmetic Products Regulation 1223/2009 and REACH Dr. Annelie Struessmann, Technical Director, CONUSBAT London, 15. October 2013 Understanding the Cosmetic Products Regulation 1223/2009
More informationBTI Marketing Ltd. Part A
BTI Marketing Ltd. Telephone 0044 (0)1403 733962 24 Crockhurst e-mail: adrianmellor@btconnect.com Southwater West Sussex RH 13 9XA England VAT No. GB 992 6906 66 Cosmetic Product Safety Report Product(s):
More informationQuestions and answers on sodium laurilsulfate used as an excipient in medicinal products for human use
9 October 2017 EMA/CHMP/606830/2014 Committee for Human Medicinal Products (CHMP) Questions and answers on sodium laurilsulfate used as an excipient in medicinal products for human use Draft agreed by
More informationOverview over ongoing ingredient issues
Overview over ongoing ingredient issues Florian Schellauf, Colipa Overview Colipa actively follows about 70 ingredient issues, 120 hair dye dossiers and monitors an additional 40 ingredient issues Therefore
More informationSCCP. Clarification of. Mixture of 5-Chloro-2-Methyl-Isothiazolin-3(2H)-one and 2- Methylisothiazolin-3(2Η)-οne. COLIPA n P56
EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON CONSUMER PRODUCTS SCCP Clarification
More informationGovernment assignment Faster adaptation of the regulations for cosmetic products. Report from the Medical Products Agency
Government assignment Faster adaptation of the regulations for cosmetic products Report from the Medical Products Agency Ref. no. 1.1.2-2017-002807 Date: January 2017 When quoting Medical Products Agency
More informationOPINION THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS
THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS OPINION CONCERNING A CLARIFICATION ON THE FORMALDEHYDE AND PARA-FORMALDEHYDE ENTRY IN DIRECTIVE 76/768/EEC ON
More informationFINAL DRAFT UGANDA STANDARD
FINAL DRAFT UGANDA STANDARD FDUS EAS 377-1 First Edition 2013-mm-dd Cosmetics and cosmetic products Part 1: List of substances prohibited in cosmetic products Reference number FDUS EAS 377-1: 2013 UNBS
More informationEU nickel restriction: background and ECHA s activities - guideline
EU nickel restriction: background and ECHA s activities - guideline Workshop on EU nickel restriction Nickel Institute 27 June 2017 Kirsi Sihvonen Risk Management Implementation Unit European Chemicals
More informationUEIL. Independent Union of the European Lubricants Industry
UEIL Independent Union of the European Lubricants Industry HSE Committee Report HSE Committee Meetings 29 th January & 14 th May 2014 Caroline Slinn Afton Chemical Caroline.Slinn@AftonChemical.com VSI
More informationOfficial Journal of the European Union
6.5.2015 EN L 115/25 COMMISSION IMPLEMENTING REGULATION (EU) 2015/724 of 5 May 2015 concerning the of retinyl acetate, retinyl palmitate and retinyl propionate as feed additives for all animal (Text with
More informationApplication of aggregate exposure in a case study. Bob Safford
Application of aggregate exposure in a case study Bob Safford Setting IFRA Standards for fragrances The current methodology for setting IFRA Standards is based on the QRA process (Api et al., 2008) Standards
More informationThe Danish EPA Survey and Health Risk Assessment of Lead in Jewellery
Scientific Committee on Health and Environmental Risks SCHER Scientific opinion on The Danish EPA Survey and Health Risk Assessment of Lead in Jewellery (Danish EPA report on the environmental and health
More informationRISKS AND HEALTH EFFECTS FROM TATTOOS, BODY PIERCING AND RELATED PRACTICES
THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS CONSULTATION CONCERNING RISKS AND HEALTH EFFECTS FROM TATTOOS, BODY PIERCING AND RELATED PRACTICES adopted by
More informationResearch & Management Consultancy
Research & Management Consultancy Partners: M. C. Perry B.Sc.(Hons), C.Biol., MRSB., M.T.O.P.R.A. R. G. Perry Consultants to the Pharmaceutical, Chemical and Allied Industries R & M Consultancy PO Box
More informationSENATE BILL No Introduced by Senator Lara. February 8, 2017
SENATE BILL No. 258 Introduced by Senator Lara February 8, 2017 An act to add Chapter 13 (commencing with Section 108950) to Part 3 of Division 104 of the Health and Safety Code, and to add Section 6414
More informationResearch & Management Consultancy Partners: M. C. Perry B.Sc.(Hons), C.Biol., MSB., M.T.O.P.R.A. R. G. Perry
Research & Management Consultancy Partners: M. C. Perry B.Sc.(Hons), C.Biol., MSB., M.T.O.P.R.A. R. G. Perry Consultants to the Pharmaceutical, Chemical and Allied Industries R & M Consultancy Sterling
More informationDr. Matteo Zanotti Russo
Dr. Matteo Zanotti Russo Angel Consulting - Italy CRCC Berlin, October 2017 What s on EU Commission Report on product claims Are we complying with EU Regulation no. 655/2013 What are Authorities inspecting?
More informationHazard and Exposure Screening Methods for HPV Categories: Amine Oxides a Case Study
Hazard and Exposure Screening Methods for HPV Categories: Amine Oxides a Case Study Hans Sanderson, PhD. Senior Adviser, Danish National Environmental Research Institute On behalf of the Soap and Detergent
More informationCosmetics: life under the EU Regulation
Cosmetics: life under the EU Regulation CW Briefing, December 2012/January 2013 / Europe Tony Stovold, reporter There are few more suitable venues for a cosmetics workshop than that chosen by the UK Society
More informationOPINION ON. Oxidative hair dye substances and hydrogen peroxide used in products to colour eyelashes
Revision of 11 December 2012 Scientific Committee on Consumer Safety SCCS OPINION ON Oxidative hair dye substances and hydrogen peroxide used in products to colour eyelashes The SCCS adopted this opinion
More informationMOTION FOR A RESOLUTION
European Parliament 2014-2019 Plenary sitting B8-0217/2018 25.4.2018 MOTION FOR A RESOLUTION further to Questions for Oral Answer B8-0017/2018 and B8-0018/2018 pursuant to Rule 128(5) of the Rules of Procedure
More informationTHE SCCP'S NOTES OF GUIDANCE FOR THE TESTING OF COSMETIC INGREDIENTS AND THEIR SAFETY EVALUATION
THE SCCP'S NOTES OF GUIDANCE FOR THE TESTING OF COSMETIC INGREDIENTS AND THEIR SAFETY EVALUATION 6 TH REVISION Adopted by the SCCP during the 10 th plenary meeting of 19 December 2006 Nam et ipsa scientia
More informationCosmetic Products New EU Regulation Published
Cosmetic Products New EU Regulation Published From 11th July 2013 cosmetic products placed on the market within the European Economic Area1 (EEA) will have to comply with the new EU Cosmetic Products Regulation
More informationCOMMISSION DIRECTIVE 2009/134/EC
29.10.2009 Official Journal of the European Union L 282/15 DIRECTIVES COMMISSION DIRECTIVE 2009/134/EC of 28 October 2009 amending Council Directive 76/768/EEC concerning cosmetic products for the purposes
More informationCOMMISSION REGULATION (EU)
EN L 315/34 Official Journal of the European Union 26.11.2013 COMMISSION REGULATION (EU) No 1197/2013 of 25 November 2013 amending Annex III to Regulation (EC) No 1223/2009 of the European Parliament and
More informationSAFETY DATA SHEET according to 1907/2006/EC, Article 31
SAFETY DATA SHEET according to 197/26/EC, Article 31 1/6 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier date 216-11-21 Product name 1.2. Relevant
More informationResearch & Management Consultancy Partners: M. C. Perry B.Sc.(Hons), C.Biol., MSB., M.T.O.P.R.A. R. G. Perry
Research & Management Consultancy Partners: M. C. Perry B.Sc.(Hons), C.Biol., MSB., M.T.O.P.R.A. R. G. Perry Consultants to the Pharmaceutical, Chemical and Allied Industries R & M Consultancy Sterling
More informationSAFETY DATA SHEET according to 1907/2006/EC, Article 31
SAFETY DATA SHEET according to 197/26/EC, Article 31 Page 1/6 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name 1.2. Relevant identified
More informationIFRA Conformity Certificate
Product Name INCI Name Product Code IFRA Conformity Certificate Lime Oil Distilled Citrus Aurantifolia WHC180 Revision No 1 Date 06.03.2017 We certify that the above compound is in compliance with the
More informationIFRA Conformity Certificate
Product Name INCI Name Organic Tangerine Oil Citrus Reticulata Peel Revision No 1 Date 25.07.2018 We certify that the above compound is in compliance with the Standards of the INTERNATIONAL FRAGRANCE ASSOCIATION
More informationSAFETY ASSESSMENT OF COSMETICS IN THE EU : TRAINING COURSE, 4 9 February 2019
SAFETY ASSESSMENT OF COSMETICS IN THE EU : TRAINING COURSE, 4 9 February 2019 PROGRAMME MONDAY 4 FEBRUARY 2019 09.00-09.15 Welcome Prof. V. Rogiers (VUB, BE) Session 1 : Key issues in safety assessment
More informationSAFETY ASSESSMENT OF COSMETICS IN THE EU : TRAINING COURSE, 5 10 February 2018
SAFETY ASSESSMENT OF COSMETICS IN THE EU : TRAINING COURSE, 5 10 February 2018 PROGRAMME MONDAY 5 FEBRUARY 2018 09.00-09.15 Welcome Prof. V. Rogiers (VUB, BE) Session 1 : Key issues in safety assessment
More informationCOMMISSION DIRECTIVE 2009/36/EC
17.4.2009 Official Journal of the European Union L 98/31 DIRECTIVES COMMISSION DIRECTIVE 2009/36/EC of 16 April 2009 amending Council Directive 76/768/EEC, concerning cosmetic, for the purpose of adapting
More informationThe EU Cosmetics Regulation
The EU Cosmetics Regulation Cosmetics Europe s Guidelines on the Product Information File Manuela Coroama Cosmetics Europe Contents The Product Information File (P.I.F.) requirement in the Cosmetics Regulation
More informationIFRA STANDARDS CONFORMITY CERTIFICATE Fragrance compound
IFRA STANDARDS CONFORMITY CERTIFICATE Fragrance compound Product: Rose Otto INCI Name: Parfum, Rosa Damascena Flower Oil We certify that the above compound is in compliance with the Standards of the INTERNATIONAL
More informationEUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL. Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCCP
EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON CONSUMER PRODUCTS SCCP Opinion on Review
More informationSafety Assessment of PEG-150 Pentaerythrityl Tetrastearate as Used in Cosmetics
Safety Assessment of PEG-150 Pentaerythrityl Tetrastearate as Used in Cosmetics Status: Final Report Release Date: June 23, 2014 Panel Date: June 9-10, 2014 The 2014 Cosmetic Ingredient Review Expert Panel
More informationEuropean Cosmetic Regulation 1223/2009
European Cosmetic Regulation 1223/2009 Main requirement SCC Ontario April 6th, 2016 Michela Pollastri Main requirement of the regulation 1223/2009: CLAIM COMMON CRITERIA PRODUCT INFORMATION FILE - P.I.F
More informationEuropean Changes and the news on the Cosmetics Regulation
European Changes and the news on the Cosmetics Regulation SCANCOS, Malmø, 5. - 6. November 2009 Annette Orloff Unit Cosmetics and Medical Devices 1 New Cosmetics Regulation Adoption: expected 26. Nov.
More informationDermal penetration according to OECD TG 428
Bisphenol A Dermal penetration ti according to OECD TG 428 Dermal penetration of bisphenol A 1 Dermal absorption of BPA Exposure Mainly via ingestion Skin contact is generally considered as marginal Skin
More informationParabens, underarm cosmetics and breast cancer
EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON CONSUMER PRODUCTS SCCP Extended Opinion
More informationEUROPEAN UNION. Brussels, 10 November 2009 (OR. en) 2008/0035 (COD) PE-CONS 3623/09 MI 152 ENT 91 CONSOM 77 SAN 74 ECO 49 ENV 302 CHIMIE 34 CODEC 535
EUROPEAN UNION THE EUROPEAN PARLIAMENT THE COUNCIL Brussels, 10 November 2009 (OR. en) 2008/0035 (COD) PE-CONS 3623/09 MI 152 ENT 91 CONSOM 77 SAN 74 ECO 49 ENV 302 CHIMIE 34 CODEC 535 LEGISLATIVE ACTS
More informationClassification of cosmetic raw materials and adjuncts
KENYA STANDARD KS 1474-1: 2011 ICS 71.100.70 Classification of cosmetic raw materials and adjuncts Part 1: Illustrative list by category of cosmetic products No copying of this standard without KEBS permission
More informationREACH AND ITS IMPACT ON COSMETICS
September 2008 REACH AND ITS IMPACT ON COSMETICS In June 2007, the European Union s Regulation (EC) No. 1907/2006 on the Registration, Evaluation, Authorization, and Restriction of Chemicals (the REACH
More informationSAFETY DATA SHEET Blocks CONQUEROR DEODORANT TOILET BLOCKS - NON PDCB
SAFETY DATA SHEET SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name Product number Internal identification A016 EV Janitorial 1.2. Relevant
More informationCOSMETICS EUROPE: N 24B HAIR DYE LABELLING - INFORMATION FOR PROFESSIONALS
COSMETICS EUROPE: N 24B HAIR DYE LABELLING - INFORMATION FOR PROFESSIONALS 2011 RECOMMENDATION N 24b LABELLING INFORMATION AND WARNINGS FOR PROFESSIONAL HAIR COLOURING PRODUCTS FINAL 2011 Note: This recommendation
More informationAustralian Standard. Sunglasses and fashion spectacles. Part 1: Safety requirements AS
AS 1067.1 1990 Australian Standard Sunglasses and fashion spectacles Part 1: Safety requirements This Australian Standard was prepared by Committee CS/53, Sunglasses. It was approved on behalf of the Council
More informationOPINION ON Methylene glycol
Revision 18 September 2012 Scientific Committee on Consumer Safety SCCS OPINION ON Methylene glycol The SCCS adopted this opinion at its 15 th plenary meeting of 26-27 June 2012 About the Scientific Committees
More informationFebruary 22, Dear Ms. Hardin,
February 22, 2016 Kristen Hardin Center for Drug Evaluation and Research Food and Drug Administration 10903 New Hampshire Ave., Bldg. 22, Rm. 5443 Silver Spring, MD 20993-0002 RE: Public Comments on Draft
More information20-23 November November ECHA Conference Centre (Annankatu 18, Helsinki)
7 November 2018 RAC/A/47/2018 Final Draft Agenda 47 th meeting of the Committee for Risk Assessment 20-23 November 2018 27-30 November 2018 ECHA Conference Centre (Annankatu 18, Helsinki) Tuesday 20 November
More informationConsumer Habits and Practices for Formulated Cleaning Products and Personal Care Products
Consumer Habits and Practices for Formulated Cleaning Products and Personal Care Products Symposium on: Exploring Global Data Resources for Consumer Exposure Assessment Presented By: Dr. Paul C. DeLeo
More informationB REGULATION (EC) No 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 30 November 2009 on cosmetic products. (OJ L 342, , p.
2009R1223 EN 11.07.2013 001.002 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B REGULATION (EC) No 1223/2009 OF THE EUROPEAN
More information(1 rwa. Personal CareNProducts Council. Kristen Hardin. Center for Drug Evaluation and Research, Food and Drug Administration
Cotm:red a Sc clv I II UI PRODUCTS ASSOCIATION Quc!jiy & Innovoion Kristen Hardin 10903 New Hampshire Avenue, Building 22, Room 5443 Silver Spring, MD 20993 2018) The Personal Care Products Council (Council)
More informationIFRA STANDARDS CONFORMITY CERTIFICATE Fragrance compound
IFRA STANDARDS CONFORMITY CERTIFICATE Fragrance compound Product: Ginger Oil Organic INCI Name: Zingiber officinale root oil We certify that the above compound is in compliance with the Standards of the
More informationCollection and Dissemination of Exposure Data for Risk Screening of Formulated Consumer Products
Collection and Dissemination of Exposure Data for Risk Screening of Formulated Consumer Products Presented By: Dr. Paul C. DeLeo Senior Director, Environmental Safety 21 st Annual Meeting of the International
More informationon the Lists of China.
Introduction on the Lists of Regulated Cosmetic Ingredients in China The document aims to explain in simple terms the types of lists for regulated cosmetic ingredients, especially the related background,
More informationTHE EUROPEAN UNION S REGULATORY ENVIRONMENT FOR COSMETICS
THE EUROPEAN UNION S REGULATORY ENVIRONMENT FOR COSMETICS 2 CONTENTS EU Cosmetics Legislation - Area of Applicability Regulatory Modules for Cosmetics Experiences gained with Regulation 1223/2009 Horizontal
More informationPreservatives & Cosmetic Micro Regulations in the EU
Recherche et Preservatives & Cosmetic Micro Regulations in the EU ylvie CUPFERMAN, Ph D Or October 2010 Recherche et Presentation Outline 1. Preservatives on the EU positive list a. New preservatives b.
More informationSOUTH AFRICAN NATIONAL STANDARD
ISBN 978-0-626-29618-6 SOUTH AFRICAN NATIONAL STANDARD Sunscreen products WARNING This document references other documents normatively. Published by SABS Standards Division 1 Dr Lategan Road Groenkloof
More informationCosmetic product claims
Cosmetic product claims Regulatory framework and the common criteria Manuela Coroama Cosmetics Europe Contents 1. Introduction 2. The EU regulatory framework for cosmetic product claims 3. The scope of
More informationCOSMETICS EUROPE: COMMISSION RECOMMENDATION ON THE EFFICACY OF SUNSCREEN PRODUCTS AND THE CLAIMS MADE RELATING THERETO
COSMETICS EUROPE: COMMISSION RECOMMENDATION ON THE EFFICACY OF SUNSCREEN PRODUCTS AND THE CLAIMS MADE RELATING THERETO SEPTEMBER 2006 26.9.2006 Official Journal of the European Union L 265/39 COMMISSION
More informationCOSMETICS REFORM EXPLAINED
COSMETICS REFORM EXPLAINED 2 BACKGROUND/ INTRO 3 Background/Intro At the Johnson & Johnson & Johnson Family of Consumer Companies, we recognize that consumer confidence is more than a formula, which is
More informationAS/NZS :2011. High visibility safety garments AS/NZS :2011. Part 1: Garments for high risk applications. Australian/New Zealand Standard
AS/NZS 4602.1:2011 Incorporating Amendment No. 1 Australian/New Zealand Standard High visibility safety garments Part 1: Garments for high risk applications Superseding AS/NZS 4602:1999 AS/NZS 4602.1:2011
More informationISO INTERNATIONAL STANDARD. Cosmetics Sun protection test methods In vivo determination of the sun protection factor (SPF)
INTERNATIONAL STANDARD ISO 24444 First edition 2010-11-15 Cosmetics Sun protection test methods In vivo determination of the sun protection factor (SPF) Cosmétiques Méthodes d'essai de protection solaire
More informationASIAN SKIN: ROLE OF UVA IN HYPERPIGMENTATION AND PREVENTION
1 RESEARCH & INNOVATION ASIAN SKIN: ROLE OF UVA IN HYPERPIGMENTATION AND PREVENTION Dominique MOYAL SUN PROTECTION & ANTI-AGEING SKIN CARE ASIA CONFERENCE 2014 CONTENT OF THE PRESENTATION The effects of
More informationIFRA Conformity Certificate
Product Name INCI Name Product Code IFRA Conformity Certificate Organic Patchouli Oil Pogostemon Cablin Leaf Oil WHC628 The Soap Kitchen Unit 8 Caddsdown Industrial Park, Clovelly Road, Bideford, Devon
More informationHazard Communication and the Globally Harmonized System (GHS) John Frowd, CAS USDOL-OSHA Manhattan Area Office
Hazard Communication and the Globally Harmonized System (GHS) John Frowd, CAS USDOL-OSHA Manhattan Area Office Frowd.john@dol.gov Brief Overview/GHS Learning Objectives Why Adopt the GHS Description of
More informationMaterial Safety Data Sheet
Material Safety Data Sheet Revision date: 11-13-2008 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Supplier: Johnson and Johnson Consumer Companies, Inc. 199 Grandview Road
More informationSAC S RESPONSE TO THE OECD ALIGNMENT ASSESSMENT
SAC S RESPONSE TO THE OECD ALIGNMENT ASSESSMENT A Collaboration Between the Sustainable Apparel Coalition and the Organisation for Economic Cooperation and Development February 13, 2019 A Global Language
More informationTips for proposers. Cécile Huet, PhD Deputy Head of Unit A1 Robotics & AI European Commission. Robotics Brokerage event 5 Dec Cécile Huet 1
Tips for proposers Cécile Huet, PhD Deputy Head of Unit A1 Robotics & AI European Commission Robotics Brokerage event 5 Dec. 2016 Cécile Huet 1 What are you looking for? MAXIMISE IMPACT OF PROGRAMME on
More informationThis document is a preview generated by EVS
INTERNATIONAL STANDARD ISO 11612 Third edition 2015-07-01 Protective clothing Clothing to protect against heat and flame Minimum performance requirements Vêtements de protection Vêtements de protection
More informationRinse-off Cosmetics. Scope
EU Ecolabel Rinse-off Cosmetics Scope Interest about scope extension JRC Seville EUEB, 28 June 2018 Scope of the current criteria* Any rinse-off substance or mixture falling under the scope of Regulation
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Tattoo Removal Prior Approval Policy Date Adopted: 16 September 2016 Version: 1617.1.01 Individual Funding Request Team Bristol, North Somerset and South
More informationBG ES CS DA DE ET EL EN FR GA HR IT LV LT HU MT NL PL PT RO SK SL FI SV. REGULATION (EC) No 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
Document 00R1 Text Document information Procedure Summary of legislation Collapse all Expand all Title and reference Regulation (EC) No 1/00 of the European Parliament and of the Council of 0 November
More informationPOSITION PAPER. Substance in Tattoo inks and permanent make-up: Proposal for a restriction. June 2018
POSITION PAPER Substance in Tattoo inks and permanent make-up: Proposal for a restriction June 2018 Contact Person at ANEC Secretariat: Alana Valero (anec@anec.eu) ANEC-PT-2018-CEG-0010 *1 List of Contents
More informationIntravenous Access and Injections Through Tattoos: Safety and Guidelines
CADTH RAPID RESPONSE REPORT: SUMMARY OF ABSTRACTS Intravenous Access and Injections Through Tattoos: Safety and Guidelines Service Line: Rapid Response Service Version: 1.0 Publication Date: August 03,
More informationNational Institute for Health and Clinical Excellence
2. Please insert the section number (eg 3.2) in the 1 st column. If your to the as a whole, please put general in this column 3. Please insert the page number (ie in the 2 nd column. The expert papers
More informationSAFETY DATA SHEET PINE GEL
SAFETY DATA SHEET SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name Product number Internal identification A097 EV Janitorial 1.2. Relevant
More informationStrengthening the Compliance to the Malaysia Cosmetic Regulation & Requirements
Strengthening the Compliance to the Malaysia Cosmetic Regulation & Requirements 1 Presentation Outline Introduction Post Market Surveillance : Challenges New updates : directives, circular & guidelines
More informationIdentification and quantification of preservative chemicals in common household products. Session 1
Background Session 1 Preservatives are chemicals that are commonly added to food or general such as toiletries and pharmaceuticals in order to increase their shelf lives. Preservatives can act as antimicrobials,
More informationSAFETY DATA SHEET according to 1907/2006/EC, Article 31
SAFETY DATA SHEET according to 1907/2006/EC, Article 31 Page 1/6 SECTION 1: Identification of the substance/mixture and of the company/undertaking Revision 0 1.1. Product identifier Product name 1.2. Relevant
More informationTO Whom It May Concern. RE: Directors of M/s Actual/Legal Manufacturer & complete address
ON THE LETTER HEAD OF MANUFACTURER. TO Whom It May Concern RE: Directors of M/s Actual/Legal Manufacturer & complete address I confirm that the Main Board Directors of (Mention company name ) are: 1. 2.
More information: Ariel with Actilift Biological Liquitabs
Date of issue: 10/01/2012 Revision date: Version: 1.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Chemical type Trade name Product code : Mixture
More informationBody Art Programs For Regulators
Local Public Health Institute of Massachusetts www.masslocalinstitute.org Subject Matter Experts Body Art Programs For Regulators Facilitator s Guide Steve Hughes, Massachusetts Department of Public Health
More informationAssessment Record. VTCT Level 4 Certificate in. Enhancing Eyebrows with. Microblading Techniques BT4C2. Learner name: Learner number: 603/1305/5
Assessment Record Learner name: Learner number: BT4C2 VTCT Level 4 Certificate in Enhancing Eyebrows with Microblading Techniques 603/1305/5 BT4C2F_v2 Qualification at a glance This is an Assessment Record
More informationREFORM THE QUASI-DRUG APPROVAL SYSTEM
REFORM THE QUASI-DRUG APPROVAL SYSTEM Reform the Quasi-Drug Approval System YEARLY STATUS REPORT: Slight Progress Having created examination guidelines for medicated shampoos and conditioners in 2014,
More informationThis lab is estimated to take 1 to 1.5 hours.
MoDRN Module: Oxybenzone versus Zinc Oxide in Sunscreen for Biology Classrooms Teacher s Notes This lab is estimated to take 1 to 1.5 hours. Oxybenzone is used in chemical- based sunscreens as a photoprotective
More informationCOSMETICS EUROPE: COSMETICS DIRECTIVE 76/768/EEC EXPLANATORY BROCHURE
COSMETICS EUROPE: COSMETICS DIRECTIVE 76/768/EEC EXPLANATORY BROCHURE JANUARY 2004 TABLE OF CONTENTS: I. Foreword p. 2 II. Objectives and scope p. 3 III. Basic principles p. 5 IV. Responsibility of the
More informationPRODUCT INFORMATION SHEET. A thin, clear liquid SAS 20 crystallises grease and oil, enabling it to be brushed or vacuumed away.
SAS 20 Page 1 of 5 SAS 20 SPOT AND STAIN REMOVER PRODUCT INFORMATION SHEET Rapidly breaks down stains Suitable for all carpets and upholstery. Ready to use formulation for ease of use. USES An effective
More informationREFORM THE QUASI-DRUG APPROVAL SYSTEM
REFORM THE QUASI-DRUG APPROVAL SYSTEM Reform the Quasi-Drug Approval System YEARLY STATUS REPORT: Progress The Ministry of Health, Labour and Welfare (MHLW) released a model template for ordinary quasi-drug
More information